← Back to patent-cliff list
倍他米松/克霉唑/硫酸庆大霉素
Tier C — Watch / tradeBetamethasone/Clotrimazole/Gentamicin Sulfate
长澳（香港）控股有限公司
Originator
2016
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：GR、CYP51A1、30S subunit
Indications (approved)：细菌感染和真菌感染
Regional status
US
-
EU
-
China
批准上市
2016-05-31
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Betamethasone/Clotrimazole/Gentamicin Sulfate?
Approved indications include: 细菌感染和真菌感染.
When does the Betamethasone/Clotrimazole/Gentamicin Sulfate patent expire?
No public expiry year is available for Betamethasone/Clotrimazole/Gentamicin Sulfate yet; this page updates once verified.
How do I get a quote for Betamethasone/Clotrimazole/Gentamicin Sulfate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24